Minimal benefit of tonsillectomy in T1-T2 tonsillar squamous cell carcinoma treated with chemoradiotherapy | Zendy

Yun-Ting Chao | Zendy; Ling-Wei Wang | Zendy; PenYuan Chu | Zendy; MuhHwa Yang | Zendy; Yen-Bin Hsu | Zendy; TsungLun Lee | Zendy; Yi-Fen Wang | Zendy; ShyhKuan Tai | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Minimal benefit of tonsillectomy in T1-T2 tonsillar squamous cell carcinoma treated with chemoradiotherapy

Author(s) -

Yun-Ting Chao,

Ling-Wei Wang,

PenYuan Chu,

MuhHwa Yang,

Yen-Bin Hsu,

TsungLun Lee,

Yi-Fen Wang,

ShyhKuan Tai

Publication year - 2016

Publication title -

journal of the chinese medical association

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.535

H-Index - 42

eISSN - 1728-7731

pISSN - 1726-4901

DOI - 10.1016/j.jcma.2016.06.001

Subject(s) - tonsillectomy , medicine , chemoradiotherapy , pathological , stage (stratigraphy) , radiation therapy , surgery , basal cell , retrospective cohort study , gastroenterology , paleontology , biology

Chemoradiotherapy (CRT) has become the mainstay of treatment for tonsillar squamous cell carcinoma (SCC). Pre-CRT tonsillectomy is frequently performed, mostly for small primary tumors (T1-T2). However, the benefits of pre-CRT tonsillectomy remain unclear.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research